Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.
about
Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays.High-resolution melting molecular signatures for rapid identification of human papillomavirus genotypesHuman papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with Amplicor HPV and Hybrid Capture 2 assays for detection of high-grade lesions of the uterine cervixFrom Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice.Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with the linear array HPV genotyping PCR assay and influence of DNA extraction method on HPV detectionEvaluation of using composite HPV genotyping assay results to monitor human papillomavirus infection burden through simulationLow initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgeryPerformance of a New HPV Cervi-Collect Collection and Transportation Kit.Comparative performance of human papillomavirus DNA testing using novel sample collection methods.Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women.Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease.Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systemsComparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.Comparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.Comparison of DNA testing strategies in monitoring human papillomavirus infection prevalence through simulation.Pilot study of prevalence of high-risk human papillomavirus genotypes in Israeli Jewish women referred for colposcopic examination.Comparison of Analytical and Clinical Performance of HPV 9G DNA Chip, PANArray HPV Genotyping Chip, and Hybrid-Capture II Assay in Cervicovaginal Swabs.Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens.Cervical cancer screening: from molecular basis to diagnostic practice, going through new technologies.Evaluation of an array-based method for human papillomavirus detection and genotyping in comparison with conventional methods used in cervical cancer screening.Comparison of the novel human papillomavirus 4 auto-capillary electrophoresis test with the hybrid capture 2 assay and with the PCR HPV typing set test in the detection of high-risk HPV including HPV 16 and 18 genotypes in cervical specimens.Commercially available assays for multiplex detection of alpha human papillomaviruses.An update review on HPV testing methods for cervical neoplasia.Comparison of digene hybrid capture 2, GeneMatrix PapilloScreen, and a PCR sequencing assay in detecting high-risk and probable high-risk oncogenic HPV genotypes in specimens from Korean women.Cervical nitric oxide release and persistence of high-risk human papillomavirus in women.Is HPV-DNA testing a useful tool in predicting low-grade squamous intraepithelial lesion outcome? A retrospective longitudinal study.Specific magnetic isolation for direct detection of HPV16.High risk human papillomavirus genotyping in clinical samples: evaluation of different commercial tests.Self- versus physician-collected samples for the follow-up of human papillomavirus-positive women in sub-Saharan Africa.
P2860
Q33587856-F2A0335A-8017-4FFC-96C3-8042145E73A6Q34390791-60A8B5FD-39A2-4982-A129-53530A55E96BQ34487394-4B111B9C-5E36-45DB-95AB-17BD39AA54FDQ34774870-98DF8748-ED5D-4AFD-BD6D-06D76279278BQ35066537-9E688207-BAEA-4BBD-9CCE-D68B3A71B3CAQ35185477-00E0E22A-3345-4EC4-917A-367214FC3626Q35419017-3CE293A4-FBD6-4445-A799-15B679C6F15EQ35585183-76122D2F-9731-48E5-BDE1-134BE6691889Q35598854-87E123D7-82DE-4850-BF23-92BB0B39AD5FQ35659008-4CC02112-3F30-448D-A9B2-DE96DC5F0D92Q35690377-1CF03F13-AB5F-4B7A-8446-F884262FF6ACQ35690716-36594A60-BC44-4508-9793-2604FEDCDAE3Q35913775-909FBFE9-5F2C-4B7D-918A-61B85BE7E0BAQ36118559-7A5EE12D-A7DD-4512-9E18-E157E3BA4948Q36184620-2CBDE97B-209E-40C0-A033-EE804DE5246CQ36673115-A462E601-AC38-4FD6-A5C8-0A788B09981DQ36719061-D2E9BAF4-1E37-4003-89B2-6C9BDC9A15BDQ36813303-5CFCB9A1-4F30-4450-8654-7C32C9AB4DA8Q37160475-C91B4011-514B-4E05-9849-3EFFE1BA196DQ37256436-FE2AABC0-6601-4B5A-8234-012929B7729CQ37284778-8D24ADC6-AE80-4FE5-8781-A9AEA6A52E69Q37800921-036FF17B-539A-40BA-8147-46001A5E771FQ38088850-D2EC7163-2AC9-48C0-A38F-4F9652512BBCQ42235610-371EAE6C-1D1B-410C-B879-B78CF97542D8Q42479703-825669E6-029E-4C9A-9E2C-0109A70127D6Q43557103-83EBB722-395C-4E41-AEE4-E25213501F18Q44525250-4A9F982D-1D4E-4F38-ADBD-CC27F35CD249Q54377755-1C4CA1B3-A6C1-41DB-A9FA-978B31E7442CQ55280306-6D6E6379-A2B5-44D0-9CCE-FDF99A3A460F
P2860
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Comparison of the Digene HC2 a ...... genotypes in cervical samples.
@ast
Comparison of the Digene HC2 a ...... genotypes in cervical samples.
@en
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus
@nl
type
label
Comparison of the Digene HC2 a ...... genotypes in cervical samples.
@ast
Comparison of the Digene HC2 a ...... genotypes in cervical samples.
@en
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus
@nl
prefLabel
Comparison of the Digene HC2 a ...... genotypes in cervical samples.
@ast
Comparison of the Digene HC2 a ...... genotypes in cervical samples.
@en
Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus
@nl
P2093
P2860
P50
P356
P1476
Comparison of the Digene HC2 a ...... genotypes in cervical samples
@en
P2093
Chiara Casadio
Elvira Benini
Laura Zorzino
Maria T Sandri
Mario Sideri
Michela Salvatici
Paola Lentati
Patrizia Dell'Orto
Rita Passerini
P2860
P304
P356
10.1128/JCM.00049-06
P407
P577
2006-06-01T00:00:00Z